Galenus medical SARS-CoV-2 / influenza A / influenza B triple inspection obtained CE certification!

Experts from the center for Disease Control and prevention have concluded that there may be a risk of influenza epidemic in spring. In addition, the recent outbreaks in various places may lead to the risk of overlapping covid-19 and influenza.

 

 

According to WHO estimates, influenza can cause 3-5 million severe cases and 290000-650000 respiratory disease-related deaths worldwide every year.

More importantly, the clinical symptoms of influenza and covid-19 are similar, and it is difficult to distinguish them. In addition, it is often confused with respiratory infections caused by other pathogens. Therefore, it is clearly mentioned in the influenza diagnosis and treatment plan and the covid-19 prevention and control plan that attention should be paid to the etiological identification of the two viruses to guide accurate diagnosis and treatment.

 

 

In April 2022, the antigen detection kit (hereinafter referred to as "triple test") developed by Tianjin Galen medical science and Technology Co., Ltd. which can be used to collect novel coronavirus, influenza A virus and influenza B virus successfully obtained CE certification.

 

 

Focus on influenza

Clinicians should pay attention to influenza patients in the differential diagnosis, especially the high-risk groups of influenza, standardize and strengthen the clinical diagnosis and treatment of influenza, reduce the occurrence of severe influenza and reduce the mortality.

Galenus medical's three joint inspection products have successfully obtained CE certification, expanding and enriching the product line of the company's infection prevention and control business, which is conducive to enhancing the international competitiveness of the company's products, and thus helping enterprises to help prevent and control the pneumonia and influenza caused by novel coronavirus infection globally.